Evoke Pharma Inc. (EVOK)
NASDAQ: EVOK
· Real-Time Price · USD
5.06
-0.09 (-1.75%)
At close: Sep 24, 2025, 3:38 PM
5.18
2.37%
After-hours: Sep 24, 2025, 06:45 PM EDT
-1.75% (1D)
| Bid | 5 |
| Market Cap | 7.89M |
| Revenue (ttm) | 12.79M |
| Net Income (ttm) | -5.38M |
| EPS (ttm) | -1.25 |
| PE Ratio (ttm) | -4.05 |
| Forward PE | 7.95 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 5.18 |
| Volume | 39,918 |
| Avg. Volume (20D) | 2,469,731 |
| Open | 5.10 |
| Previous Close | 5.15 |
| Day's Range | 5.02 - 5.18 |
| 52-Week Range | 1.94 - 12.32 |
| Beta | -0.13 |
| Ex-Dividend Date | n/a |
About EVOK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVOK
Website n/a
Evoke Pharma Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+8.75%
Shares are trading higher after the company announ...
Unlock content with
Pro Subscription
2 months ago
+162.78%
Evoke Pharma shares are trading higher after the company announced it received a notice of allowance for the U.S. patent application covering GIMOTI in patients with moderate to severe symptoms of Gastroparesis.
